Topical dermatologic drug
-
Part 3 book "Small animal clinical pharmacology and therapeutics" includes content: Drugs and reproduction, topical dermatological therapy, ocular clinical pharmacology, regulatory issues, conversions, equivalents, and abbreviations, sample pharmaceutical calculations, nutrition and pharmacology, clinical toxicology, generic and trade names, conversions of weight to body surface area.
448p muasambanhan03 25-12-2023 2 1 Download
-
Part 2 book "Diagnostics and therapy in veterinary dermatology" includes content: Medical management of acute and chronic otitis what is the difference between brand name, generic, and compounded drugs; topical therapies; antimicrobial resistance immunopharmacology; allergen immunotherapy; biologic therapies for dermatologic use,... and other contents.
118p oursky05 23-10-2023 4 3 Download
-
Part 2 book "Handbook of veterinary pharmacology" includes content: Respiratory pharmacology, drugs acting on the gastrointestinal tract, endocrine pharmacology, topical dermatology therapy, ocular pharmacology, antimicrobial drugs, antiparasitic agents, antineoplastic drugs, fluid and blood therapy, drug interactions and adverse drug reactions... and other contents.
330p oursky05 20-09-2023 4 2 Download
-
Ebook "Plumb’s veterinary drug handbook (7th edition)" continues with its mission to serve as a single volume reference to assist veterinarians, other health professionals, and animal caretakers in providing optimal drug therapy for veterinary patients. In addition to updating all the monographs, 20+ new systemic drug full monographs (see below) and several new ophthalmic and topical dermatologic drug monographs have been added. Additional information on compounding dosage forms has been added to many monographs.
4053p lytamnguyet 04-08-2023 4 2 Download
-
Impetigo continues to be an important paediatric skin infection. Staphylococcus aureus is the commonest bacteria associated with Impetigo. Drug resistance particularly to first line oral antibiotics is alarmingly high in Staphylococcus aureus. This study aims to find the bacterial isolates causing impetigo and their susceptibility pattern to drugs particularly Mupirocin. This prospective study was done in patients presenting with impetigo to the dermatology OP of a tertiary care hospital for the period of six months from May 2017 to October 2017.
7p caygaocaolon3 27-02-2020 25 0 Download
-
Objective: To evaluate the efficacy and safety of the drug in the treatment of tinea. Subjects and methods: 29 patients with mild, moderate lesions of ringworm take topical terbinafine 1% for 2 - 4 weeks (group 1); 27 patients with extensive tinea or respond poorly to topical treatment take a combination of topical and oral terbinafine for 1 - 14 days (group 2).
6p jangni4 20-04-2018 32 0 Download
-
Dermatologic Diseases See Tables 32-1, 32-2, and 32-3 and Chaps. 52, 53, 54, 55, and 56.
5p ongxaemnumber1 29-11-2010 88 5 Download